VulnerabilityModified
CVE-2023-37613
A cross-site scripting (XSS) vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter.
MEDIUM 6.1EPSS 0.43%
Does this matter?
Lower severity and a low EPSS score (0.43%). Track it; it rarely justifies an emergency change on its own.
Description
A cross-site scripting (XSS) vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter.
- CVSS 3.1
- 6.1 MEDIUMCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
- EPSS
- 0.43% probability · 37th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-79
- Affected
- assemblysoftware/trialworks
- Source
- cve@mitre.org
References
- https://github.com/HeidiSecurities/CVEs/blob/main/CVE-2023-37613/Trialworks.mdExploit, Third Party Advisory
- https://github.com/HeidiSecurities/CVEs/blob/main/Trialworks.mdBroken Link
- https://github.com/HeidiSecurities/CVEs/blob/main/CVE-2023-37613/Trialworks.mdExploit, Third Party Advisory
- https://github.com/HeidiSecurities/CVEs/blob/main/Trialworks.mdBroken Link
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.